Joshua Stokar

13PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Orthodontics and dentofacial orthopaedicsStudies of men and masculinitiesAutoimmunityOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 21, 2026
Risk of significant liver enzyme elevation after switching antithyroid drugs.

|Jun 16, 2026
Risk of medication-related osteonecrosis of the jaw during romosozumab treatment.

|Jan 10, 2026
Earlier Menopause and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Global Cohort Study.

Joshua Stokar, Rivka Dresner-Pollak

|Nov 17, 2025
Sclerosing Cholangitis and Multiple Liver Abscesses in a Patient with Thymoma, Myasthenia Gravis, and Immune Deficiency (Good's Syndrome).

Shaul Yaari, Joshua Stokar, Yehonatan Bar Moshe

|Nov 03, 2025
Long-Term Glucagon-Like Peptide 1 Receptor Agonist Use Is Not Associated With Increased Risk of Thyroid Cancer in Adults With Type 2 Diabetes.

Rena Pollack, Joshua Stokar

|May 25, 2024
Cardiac Left Ventricular miRNA-26a Is Downregulated in Ovariectomized Mice, Upregulated upon 17-Beta Estradiol Replacement, and Inversely Correlated with Collagen Type 1 Gene Expression.

Elishai Assayag, Irina Gurt, Einav Cohen-Kfir

Pageof 3

Frequent Collaborators

2 joint publications

Asher Shafrir

2 joint publications

Rena Pollack

1 joint publications

Tair Ben-Porat

1 joint publications

Ram Elazari